IP Library › Granted Patent US 8,673,016
Granted Patent B2
US 8,673,016 · App. 13/448,965 · Granted Mar 18, 2014

Devices and methods for tissue engineering

Inventor: James Jenq Liu (Mason, OH)
Assignee: Bio2 Technologies, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,673,016
App. No.
13/448,965
Granted
Mar 18, 2014
Kind
B2
Abstract

A resorbable tissue scaffold fabricated from bioactive glass fiber forms a rigid three-dimensional porous matrix having a bioactive composition. Porosity in the form of interconnected pore space is provided by the space between the bioactive glass fiber in the porous matrix. Strength of the bioresorbable matrix is provided by bioactive glass that fuses and bonds the bioactive glass fiber into the rigid three-dimensional matrix. The resorbable tissue scaffold supports tissue in-growth to provide osteoconductivity as a resorbable tissue scaffold, used for the repair of damaged and/or diseased bone tissue.

Claims (16)

1. A synthetic bone prosthesis comprising:

intertangled bioactive glass fibers;

bonds between the intertangled bioactive glass fibers to form a rigid three-dimensional tissue scaffold;

the bioactive glass fibers having crystal phase;

pore space within the rigid three-dimensional tissue scaffold predetermined by volatile components, the volatile components being interspersed within the intertangled bioactive fibers and removed during the formation of the bonds; and

the crystal phase and the bonds formed using an exothermic reaction of the volatile components

wherein the pore space creates a porosity between 40% and 85% in the synthetic bone prosthesis

wherein the intertangled bioactive glass fiber comprises a mixture of bioactive glass fiber having different compositions

wherein the mixture of bioactive glass fiber having different compositions comprises a bioactive fiber having a first composition and a bioactive fiber having a second composition and wherein the bioglass fibers having a crystal phase is one of the bioactive fibers having a first composition and the bioactive fibers having a second composition.

2. The synthetic bone prosthesis according to claim 1 wherein the volatile components comprises a pore former.

3. The synthetic bone prosthesis according to claim 1 wherein the pore space has a pore size between 10 μm and 500 μm.

4. The synthetic bone prosthesis according to claim 1 wherein the pore size has a bi-modal size distribution.

5. The synthetic bone prosthesis according to claim 1 wherein the intertangled bioactive glass fibers have a composition comprising sodium carbonate, calcium carbonate, phosphorus pentoxide, 45 mol % to 60 mol % silica, and 2 to 10 molar ratio of calcium to phosphate.

6. The synthetic bone prosthesis according to claim 1 wherein the intertangled bioactive glass fibers comprise 13-93 glass fiber.

7. The synethetic bone prosthesis according to claim 1 wherein the intertangled bioactive glass fibers have diameter ranging from 1 μm to 200 μm.

8. The synthetic bone prosthesis according to claim 1 wherein the bonds are glass bonds.

Assignments (4)
SECURITY INTEREST Recorded Dec 3, 2021
From: NOVUM MEDICAL, INC.
To: DSM VENTURING B.V.
Reel/Frame 058283/0638 →
CHANGE OF NAME Recorded Apr 8, 2021
From: BIO2 TECHNOLOGIES, INC.
To: NOVUM MEDICAL, INC.
Reel/Frame 055872/0900 →
SECURITY INTEREST Recorded Dec 8, 2020
From: BIO2 TECHNOLOGIES, INC.
To: DSM VENTURING B.V.
Reel/Frame 054577/0284 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 18, 2012
From: LIU, JAMES J.
To: BIO2 TECHNOLOGIES, INC.
Reel/Frame 028062/0699 →
Continuity (4)
Division 12832394 · Jul 8, 2010
Provisional Application 61224675 · Jul 10, 2009
Provisional Application 61234768 · Aug 18, 2009
Related Publication 20120203355A1 · Aug 9, 2012